Clinical Trial Update: SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic body radiotherapy in combination with rhGM-CSF and thymosin alpha-1 for stage IV non-small cell lung cancer patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Leukine (sargramostim)
• ZADAXIN (Thymosin alpha-1)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Lung Cancer Metastatic | Phase 2 | Status: UNKNOWN